Stock A100120 VIEWORKS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Vieworks Co., Ltd.

Equities

A100120

KR7100120005

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 25/04/2024 BST 		5-day change 1st Jan Change
27,450 KRW +0.55% Intraday chart for Vieworks Co., Ltd. +0.55% +1.67%
2023 Vieworks Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
2023 Vieworks' Vivix X-Ray Flat Panel Detector Full Line-Up to Be Showcased At Ecr 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 310,434 286,768 390,249 276,835 247,912 251,125 - -
Enterprise Value (EV) 2 310.4 286.8 369.8 284.5 247.9 235.3 234.8 251.1
P/E ratio 12.8 x 12.7 x 11.6 x 10.4 x 16.8 x 9.54 x 8.26 x 7.96 x
Yield 1.27% 1.48% 1.79% 2.32% - 2.49% 2.61% 2.55%
Capitalization / Revenue 2.28 x 1.79 x 2.02 x 1.16 x 1.13 x 1.04 x 0.95 x 0.94 x
EV / Revenue 2.28 x 1.79 x 1.91 x 1.2 x 1.13 x 0.98 x 0.89 x 0.94 x
EV / EBITDA 10.4 x 8.71 x 9.16 x 5.72 x 9.64 x 5.45 x 4.87 x 5.58 x
EV / FCF 29.4 x -17 x 34.6 x -19.1 x - 12.4 x 9.78 x -
FCF Yield 3.41% -5.9% 2.89% -5.25% - 8.07% 10.2% -
Price to Book 1.92 x 1.7 x 2.08 x 1.32 x - 1.1 x 0.99 x 0.91 x
Nbr of stocks (in thousands) 9,855 9,449 9,314 9,182 9,182 9,182 - -
Reference price 3 31,500 30,350 41,900 30,150 27,000 27,450 27,450 27,450
Announcement Date 11/02/20 09/02/21 14/02/22 13/02/23 07/02/24 - - -
1KRW in Million2KRW in Billions3KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 136 160.3 193.1 237.9 220.3 240.7 263.5 266
EBITDA 1 29.88 32.92 40.37 49.78 25.73 43.2 48.2 45
EBIT 1 26.41 29.07 34.84 43.42 18.74 35.97 41.63 40
Operating Margin 19.42% 18.14% 18.04% 18.25% 8.51% 14.94% 15.8% 15.04%
Earnings before Tax (EBT) 1 30.16 27.98 39.64 32.82 16.69 36.27 41.63 43
Net income 1 24.22 22.89 33.7 26.49 14.76 28.8 33.13 34
Net margin 17.81% 14.28% 17.45% 11.13% 6.7% 11.96% 12.57% 12.78%
EPS 2 2,457 2,395 3,600 2,890 1,603 2,877 3,323 3,447
Free Cash Flow 3 10,572 -16,918 10,680 -14,930 - 19,000 24,000 -
FCF margin 7,773.92% -10,556.32% 5,529.55% -6,275.04% - 7,892.55% 9,107.01% -
FCF Conversion (EBITDA) 35,383.77% - 26,454.42% - - 43,981.48% 49,792.53% -
FCF Conversion (Net income) 43,655.03% - 31,687.32% - - 65,972.22% 72,434.61% -
Dividend per Share 2 400.0 450.0 750.0 700.0 - 683.3 716.7 700.0
Announcement Date 11/02/20 09/02/21 14/02/22 13/02/23 07/02/24 - - -
1KRW in Billions2KRW3KRW in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 47.1 54.84 53.96 63.67 55.14 65.16 54.83 51.32 51.62 62.49 55 55 58 67
EBITDA - - - - - - - - - - - - - -
EBIT 1 9.646 7.046 9.906 16.01 7.616 9.891 5.856 0.147 5.836 6.898 9 9 9 10
Operating Margin 20.48% 12.85% 18.36% 25.14% 13.81% 15.18% 10.68% 0.29% 11.31% 11.04% 16.36% 16.36% 15.52% 14.93%
Earnings before Tax (EBT) 10.79 7.65 8.768 10.82 -4.181 17.42 - - - - - - - -
Net income 1 8.581 7.888 7.542 7.815 -3.413 14.55 5.301 -1.195 5.799 4.81 8 7 9 6
Net margin 18.22% 14.38% 13.98% 12.27% -6.19% 22.32% 9.67% -2.33% 11.23% 7.7% 14.55% 12.73% 15.52% 8.96%
EPS - - - - - - - - - - - - - -
Dividend per Share - - - - - - - - - - - - - -
Announcement Date 01/11/21 14/02/22 02/05/22 27/07/22 01/11/22 13/02/23 03/05/23 02/08/23 01/11/23 07/02/24 - - - -
1KRW in Billions
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - 7.71 - - - -
Net Cash position 1 - - 20.5 - - 15.8 16.3 -
Leverage (Debt/EBITDA) - - - 0.1549 x - - - -
Free Cash Flow 2 10,572 -16,918 10,680 -14,930 - 19,000 24,000 -
ROE (net income / shareholders' equity) 16% 13.8% 18.8% 13.4% 6.95% 12.5% 13% 12%
ROA (Net income/ Total Assets) 14.4% 12.1% 15.4% 10% - 9.67% 10.5% 11.7%
Assets 1 168.7 188.9 218.7 264.2 - 297.9 316.6 290.6
Book Value Per Share 3 16,379 17,808 20,110 22,784 - 24,969 27,665 30,019
Cash Flow per Share 3 1,896 658.0 5,431 6,076 - 3,935 4,590 -
Capex 1 8.11 23.2 4.68 13.4 - 9.3 9.35 -
Capex / Sales 5.96% 14.48% 2.42% 5.65% - 3.86% 3.55% -
Announcement Date 11/02/20 09/02/21 14/02/22 13/02/23 07/02/24 - - -
1KRW in Billions2KRW in Million3KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Vieworks Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
27,450 KRW
Average target price
40,000 KRW
Spread / Average Target
+45.72%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Imaging Systems

1st Jan change Capi.
VIEWORKS CO., LTD. Stock Vieworks Co., Ltd.
+1.67% 183M
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD. Stock Shanghai United Imaging Healthcare Co., Ltd.
-5.77% 14.6B
IRAY TECHNOLOGY COMPANY LIMITED Stock iRay Technology Company Limited
-40.71% 2.71B
SONOSCAPE MEDICAL CORP. Stock SonoScape Medical Corp.
-12.92% 2.44B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Wandong Medical Technology Co.,Ltd.
-8.78% 1.51B
CORETAG, INC. Stock Coretag, Inc.
-.--% 1.12B
NANO-X IMAGING LTD. Stock Nano-X Imaging Ltd.
+40.04% 518M
DETECTION TECHNOLOGY OYJ Stock Detection Technology Oyj
+12.41% 239M
INTROMEDIC CO., LTD. Stock IntroMedic Co., Ltd.
-.--% 168M
CARERAY DIGITAL MEDICAL TECHNOLOGY CO., LTD. Stock CareRay Digital Medical Technology Co., Ltd.
-34.20% 163M
Medical Imaging Systems
  1. Stock Market
  2. Equities
  3. A100120 Stock
  4. Financials Vieworks Co., Ltd.